Increasing number of conferences and seminars, risk of side-effects associated with allopathic medications, unhealthy lifestyle, and rising usage of traditional medicines and therapies, directly pose a positive impact on the market growth
NEW YORK, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Global complementary and alternative medicines market is expected to generate $271.8 billion revenue by 2024, advancing at a CAGR of 6.0% during the forecast period, according to the research report published by P&S Intelligence
On the basis of type, the complementary and alternative medicines market is classified into nature-based, mind-body intervention-based, manipulative body-based, and energy-based. Among these, nature-based complementary and alternative medicines (CAM) held the largest share in 2018, and the category is further expected to hold 39.9% share by 2024. This is attributed to low side-effects of homeopathic medicines, increasing demand for the prevention and management of medical conditions, and inexpensive nature of CAM products.
Request to get the sample pages at @ https://www.psmarketresearch.com/market-analysis/complementary-and-alternative-medicines-market/report-sample
In the complementary and alternative medicines market, the nature-based CAM are further categorized into Ayurveda, homeopathic, mud therapy, and others. Of these, Ayurveda is expected to be the fastest growing category during the forecast period, mainly due to its health benefits, including reducing stress, maintaining body weight, curing insomnia, reducing inflammation, preventing diabetes, and improving high-blood pressure. Moreover, Ayurvedic medicines are non-invasive and inexpensive in nature.
Browse report overview with detailed TOC on "Complementary and Alternative Medicines (CAM) Market Research Report: by Type (Ayurveda, Homeopathic, Mud therapy, Yoga, Meditation, Tai Chi, and Qigong, Biofeedback, Guided Imagery, Hypnosis, Chiropractic, Physiotherapy, Massage, Acupuncture, Reiki, Electromagnetic Therapy), Application (Depression and Anxiety, Pain Management, Chronic Diseases, Neurological Disorders, Infertility, Skin Disorders, Weight Loss), Geographical Outlook (U.S. Canada, Germany, France, U.K., Spain, Italy, Russia, Denmark, Poland, China, Japan, India, Australia, Singapore, Indonesia, Sri Lanka, Malaysia, Thailand, South Korea, Mexico, Brazil, Argentina, Chile, Colombia, Mexico, Brazil, Argentina, Chile, Colombia, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Kuwait) – Global Industry Analysis and Forecast to 2024"at:https://www.psmarketresearch.com/market-analysis/complementary-and-alternative-medicines-market
On the basis of application, the complementary and alternative medicines market is classified into depression and anxiety, pain management, chronic diseases, neurological disorders, infertility, skin disorders, and weight loss. Among these, CAM are frequently used in the management of depression and anxiety, owing to the hectic life schedule and increasing work and societal pressure. This category held the largest revenue share, with a contribution of 41.9%, in 2018 and is further expected to reach 43.0% by 2024.
The complementary and alternative medicines market in APAC is expected to witness lucrative growth, with a CAGR of 6.8%, during the forecast period. This is mainly due to increasing usage of traditional medicines and therapies, side-effects associated with allopathic medicines, rising prevalence of chronic diseases, and growing geriatric population.
Make an enquiry before purchase @ https://www.psmarketresearch.com/send-enquiry?enquiry-url=complementary-and-alternative-medicines-market
The global complementary and alternative medicines market is fragmented in nature. Cipla Limited, Boiron, Dabur India Ltd., Novartis AG, Weleda AG, Arya Vaidya Pharmacy, Pekana-Naturheilmittel GmbH, and Biologische Heilmittel Heel GmbH are some of the major players engaged in the CAM industry.
In February 2019, Dabur India Ltd. launched two new Ayurvedic products, Ratnaprash and Hridayasava, to enhance its Ayurvedic healthcare product portfolio. Similarly, in October 2018, Weleda AG announced the expansion of its product line of Weleda Skin Food by launching new body butter, lip balm, and lightweight moisturizer.
More Reports by P&S Intelligence
Negative Pressure Wound Therapy (NPWT) Market
In the U.S., the negative pressure wound therapy market is expected to generate $790.5 million revenue by 2024, observing a CAGR of 6.7% during the forecast period, owing to the extensive wound epidemiology in the country. The prevalent cases of chronic wounds increased from 5,788,966 cases in 2016 to 6,362,965 cases in 2028 in the country.
Skin Replacement and Substitutes Market
The skin replacement and substitutes market in APAC is expected to witness lucrative growth, witnessing a CAGR of 6.7% during the forecast period. The market in APAC is led by factors such as increasing cases of burns, rising prevalence of skin diseases, and improving healthcare systems.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Connect with us: LinkedIn | Twitter | Facebook
Blogs: http://factsight.org/ | http://marketintelligencenews.com/